Henry Chi Hang Fung, MD, FRCPE

Request an Appointment Online - Click Here New patients can request an appointment online or call
888-FOX-CHASE

Fox Chase Cancer Center
333 Cottman Ave
Philadelphia, PA 19111

Video: Henry Chi Hang Fung, MD, FRCPE

Henry Chi Hang Fung, MD, FRCPE
Henry Chi Hang Fung, MD, FRCPE

Medical Oncology

Director,
Hematologic Oncology Treatment Team
Director,
Bone Marrow Transplant Program

Meet other members of the
Hematologic Oncology Treatment Team.
More information about the 
Bone Marrow Transplant Program.

Clinical Expertise:

Multiple Myeloma, lymphoma, Blood and Marrow Transplantation

Certifications:

FRCPE, awarded by Royal College of Physician Edinburgh, 01/2001;
MRCP (UK), awarded by Royal College of  Physicians, United Kingdom 10/1991

Medical Education

MBChB Medicine, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, 1987

Residencies

Hematology/Oncology, Queen Mary Hospital, Hong Kong University, 1991-1992;
Internal Medicine, Queen Mary Hospital, Hong Kong University, 1988-1991

Fellowships

Fellow, Hematology/Oncology, Queen Mary Hospital, Hong Kong University, Hong Kong;
Clinical Fellow, Division of Hematology, Vancouver Hospital and Health, Science Center, British Columbia Cancer Control Agency, University of British Columbia, Canada, 1992-1994

Honors and Awards

The Leading Physicians of the World, Top Oncologist in Chicago, International
Association of Oncologist, 2013;
Innovation Award (Henry C Fung MD and Rush SCT Program) – Chicago Chapter, American College of Health Executives, 2013;
Excellence Award, Chicago Chapter, Lymphoma Research Foundation, 2008;
Who’s Who in Medicine and Healthcare, 2007 – present;
Fellow, Royal College of Physicians Edinburgh, United Kingdom, 2001

Professional Societies

American College of Physicians;
American Society of Hematology;
American Society of Clinical Oncology;
American Society of Blood and Marrow Transplantation;
Royal College of Physicians, Edinburgh, United Kingdom

Research Interests

Allogeneic Stem Cell Transplant using alternative donors; Treatment and Stem Cell Transplant for Multiple Myeloma, Lymphoma and Leukemias, Myelodysplasia, Myeloproliferative disease and Myelofibrosis.